ETV6 and neoplasm: Notably, re-stimulation with ANRU tumor cells triggered a stronger T-cell activation than re-stimulation with the neoantigen 9mer peptide, ETV6, in CD8+ T cells previously enriched by DC loaded with the same peptide (Figures 3A, B).